Actualización en hipertensión arterial pulmonar

Translated title of the contribution: Update in pulmonary arterial hypertension

C. R. Mejía Chew, S. Alcolea Batres, J. J. Ríos Blanco

Research output: Contribution to journalShort surveypeer-review

3 Scopus citations


Pulmonary arterial hypertension is a rare and progressive disease that mainly affects the pulmonary arterioles (precapillary), regardless of the triggering aetiology. The prevalence of pulmonary hypertension and pulmonary arterial hypertension in Spain is estimated at 19.2 and 16 cases per million inhabitants, respectively. The diagnosis of pulmonary arterial hypertension is based on haemodynamic criteria (mean pulmonary artery pressure ≥25 mmHg, pulmonary capillary wedge pressure ≤15 mmHg and pulmonary vascular resistance >3 Wood units) and therefore requires the implementation of right cardiac catheterisation. Sequential therapy with a single drug has been used in clinical practice. However, recent European guidelines recommend combined initial therapy in some situations. This review conducts a critical update of our knowledge of this disease according to the latest guidelines and recommendations.

Translated title of the contributionUpdate in pulmonary arterial hypertension
Original languageSpanish
Pages (from-to)436-444
Number of pages9
JournalRevista Clinica Espanola
Issue number8
StatePublished - Nov 1 2016


  • Endothelin receptor antagonist
  • Phosphodiesterase type 5 inhibitors
  • Prostacyclin analogues
  • Pulmonary arterial hypertension
  • Pulmonary hypertension
  • Review


Dive into the research topics of 'Update in pulmonary arterial hypertension'. Together they form a unique fingerprint.

Cite this